{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:15:21Z","timestamp":1790651721882,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460032"],"award-info":[{"award-number":["82460032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022978","name":"Health Commission of Yunnan Province","doi-asserted-by":"publisher","award":["XDYC-YLWS-2023\\u20130004"],"award-info":[{"award-number":["XDYC-YLWS-2023\\u20130004"]}],"id":[{"id":"10.13039\/100022978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019413","name":"Yunnan Provincial Department of Education Science Research Fund Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202401AY070001\\u2013047"],"award-info":[{"award-number":["202401AY070001\\u2013047"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007846","name":"Yunnan Provincial Department of Education","doi-asserted-by":"publisher","award":["2024Y921"],"award-info":[{"award-number":["2024Y921"]}],"id":[{"id":"10.13039\/501100007846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.leukres.2025.108119","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:40:41Z","timestamp":1760114441000},"page":"108119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["IGF2BP3 promotes acute myeloid leukemia cell progression by regulating Semaphorin 4D stability in an m6A-dependent manner"],"prefix":"10.1016","volume":"159","author":[{"given":"Juan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyang","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianle","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanzhen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-8446","authenticated-orcid":false,"given":"Hongchao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2025.108119_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pcl.2014.09.007","article-title":"Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants","volume":"62","author":"Tarlock","year":"2015","journal-title":"Pediatr. Clin. North Am."},{"issue":"27","key":"10.1016\/j.leukres.2025.108119_bib2","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","article-title":"Collaborative efforts driving progress in pediatric acute myeloid leukemia","volume":"33","author":"Zwaan","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.108119_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcancer.2021.03.034","article-title":"Precision Medicine in myeloid malignancies","volume":"84","author":"Westermann","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.leukres.2025.108119_bib4","first-page":"11780","article-title":"Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation","volume":"93","author":"Hall","year":"1996"},{"issue":"2","key":"10.1016\/j.leukres.2025.108119_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jdermsci.2015.05.002","article-title":"Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion","volume":"79","author":"Cao","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.leukres.2025.108119_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.04.013","article-title":"CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis","volume":"455","author":"Zhang","year":"2019","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.leukres.2025.108119_bib7","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/ijc.31958","article-title":"The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms","volume":"144","author":"Xia","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.leukres.2025.108119_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s11658-017-0058-9","article-title":"VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer","volume":"23","author":"Chen","year":"2018","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.leukres.2025.108119_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/cncr.22764","article-title":"Prognostic significance of CD100 expression in soft tissue sarcoma","volume":"110","author":"Ch'ng","year":"2007","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.leukres.2025.108119_bib10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20072602","article-title":"Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. the","volume":"205","author":"Sierra","year":"2008","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.leukres.2025.108119_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/ncb843","article-title":"The semaphorin 4D receptor controls invasive growth by coupling with met","volume":"4","author":"Giordano","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.leukres.2025.108119_bib12","first-page":"1189","article-title":"The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer","volume":"9","author":"Ding","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.leukres.2025.108119_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/19420862.2015.1102813","article-title":"Generation and preclinical characterization of an antibody specific for SEMA4D","volume":"8","author":"Fisher","year":"2016","journal-title":"mAbs"},{"issue":"4","key":"10.1016\/j.leukres.2025.108119_bib14","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.7952","article-title":"Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K\/AKT and ERK signaling pathways","volume":"45","author":"Jiang","year":"2021","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2025.108119_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1182\/blood-2015-07-604512","article-title":"Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia","volume":"127","author":"Wouters","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2025.108119_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m(6)A modification in coding and Non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.leukres.2025.108119_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.leukres.2025.108119_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.leukres.2025.108119_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.leukres.2025.108119_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MOH.0000000000000636","article-title":"The N6-methyladenosine RNA modification in acute myeloid leukemia","volume":"28","author":"Yankova","year":"2021","journal-title":"Curr. Opin. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2025.108119_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030650","article-title":"Messenger RNA Life-Cycle in cancer cells: emerging role of conventional and Non-Conventional RNA-Binding proteins?","volume":"19","author":"Coppin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.leukres.2025.108119_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","article-title":"The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability","volume":"54","author":"Zhang","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"15","key":"10.1016\/j.leukres.2025.108119_bib23","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?","volume":"70","author":"Bell","year":"2013","journal-title":"Cell. Mol. life Sci. CMLS"},{"key":"10.1016\/j.leukres.2025.108119_bib24","doi-asserted-by":"crossref","first-page":"1071675","DOI":"10.3389\/fimmu.2023.1071675","article-title":"Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.leukres.2025.108119_bib25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.22459","article-title":"RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma","volume":"48","author":"Jeng","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.leukres.2025.108119_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","article-title":"RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer","volume":"39","author":"Yang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.leukres.2025.108119_bib27","first-page":"125","article-title":"Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck","volume":"42","author":"Clauditz","year":"2013","journal-title":"J. Oral. Pathol. Med. Off. Publ. Int. Assoc. Oral. Pathol. Am. Acad. Oral. Pathol."},{"key":"10.1016\/j.leukres.2025.108119_bib28","article-title":"IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells","volume":"17","author":"Xu","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"48","key":"10.1016\/j.leukres.2025.108119_bib29","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1038\/s41388-023-02865-6","article-title":"The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.leukres.2025.108119_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw104","article-title":"SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features","volume":"44","author":"Zhou","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.leukres.2025.108119_bib31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1471-4906(01)02087-7","article-title":"The CD100-CD72 interaction: a novel mechanism of immune regulation","volume":"22","author":"Kumanogoh","year":"2001","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.leukres.2025.108119_bib32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmg.39.8.575","article-title":"Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome","volume":"39","author":"Monk","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.leukres.2025.108119_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2014.07.006","article-title":"The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer","volume":"29","author":"Lederer","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.leukres.2025.108119_bib34","article-title":"Knockdown of m6A reader IGF2BP3 inhibited Hypoxia-Induced cell migration and angiogenesis by regulating hypoxia inducible Factor-1\u03b1 in stomach cancer","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.leukres.2025.108119_bib35","article-title":"Enterolactone combined with m6A reader IGF2BP3 inhibits malignant angiogenesis and disease progression in ovarian cancer","volume":"136","author":"Xu","year":"2025","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"issue":"18","key":"10.1016\/j.leukres.2025.108119_bib36","doi-asserted-by":"crossref","first-page":"18517","DOI":"10.1074\/jbc.M500270200","article-title":"The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells","volume":"280","author":"Liao","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.leukres.2025.108119_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1189\/jlb.2A0414-228RR","article-title":"IL-18-induced interaction between IMP3 and HuR contributes to COX-2 mRNA stabilization in acute myeloid leukemia","volume":"99","author":"Ko","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.leukres.2025.108119_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12967-022-03500-w","article-title":"SEMA4D\/PlexinB1 promotes AML progression via activation of PI3K\/Akt signaling","volume":"20","author":"Liu","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.leukres.2025.108119_bib39","doi-asserted-by":"crossref","first-page":"1384471","DOI":"10.1155\/2022\/1384471","article-title":"Soluble Sema4D level is positively correlated with Sema4D expression in PBMCs and peripheral blast number in acute leukemia","volume":"2022","author":"Xue","year":"2022","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.leukres.2025.108119_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625006095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:16:43Z","timestamp":1773825403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625006095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"alternative-id":["S0145212625006095"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108119","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF2BP3 promotes acute myeloid leukemia cell progression by regulating Semaphorin 4D stability in an m6A-dependent manner","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.108119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108119"}}